tiprankstipranks
Trending News
More News >
Ambu A/S Class B (AMBFF)
OTHER OTC:AMBFF
Advertisement

Ambu (AMBFF) Price & Analysis

Compare
37 Followers

AMBFF Stock Chart & Stats


Ambu News

AMBFF FAQ

What was Ambu A/S Class B’s price range in the past 12 months?
Ambu A/S Class B lowest stock price was $13.20 and its highest was $23.45 in the past 12 months.
    What is Ambu A/S Class B’s market cap?
    Ambu A/S Class B’s market cap is $4.06B.
      When is Ambu A/S Class B’s upcoming earnings report date?
      Ambu A/S Class B’s upcoming earnings report date is Nov 05, 2025 which is in 68 days.
        How were Ambu A/S Class B’s earnings last quarter?
        Ambu A/S Class B released its earnings results on Aug 22, 2025. The company reported $0.072 earnings per share for the quarter, missing the consensus estimate of $0.085 by -$0.014.
          Is Ambu A/S Class B overvalued?
          According to Wall Street analysts Ambu A/S Class B’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Ambu A/S Class B pay dividends?
            Ambu A/S Class B pays a Annually dividend of $0.008 which represents an annual dividend yield of 0.05%. See more information on Ambu A/S Class B dividends here
              What is Ambu A/S Class B’s EPS estimate?
              Ambu A/S Class B’s EPS estimate is 0.07.
                How many shares outstanding does Ambu A/S Class B have?
                Ambu A/S Class B has 234,974,400 shares outstanding.
                  What happened to Ambu A/S Class B’s price movement after its last earnings report?
                  Ambu A/S Class B reported an EPS of $0.072 in its last earnings report, missing expectations of $0.085. Following the earnings report the stock price went up 4.079%.
                    Which hedge fund is a major shareholder of Ambu A/S Class B?
                    Currently, no hedge funds are holding shares in AMBFF

                    Company Description

                    Ambu A/S Class B

                    Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

                    Ambu (AMBFF) Earnings & Revenues

                    AMBFF Company Deck

                    AMBFF Earnings Call

                    Q3 2025
                    0:00 / 0:00
                    Earnings Call Sentiment|Neutral
                    The earnings call presented strong growth in revenue and strategic advancements, particularly in the Endoscopy segment. However, challenges in the GI segment and potential contract losses in Anaesthesia & Patient Monitoring were noted.View all AMBFF earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Teleflex
                    Conmed
                    Merit Medical Systems
                    Insulet
                    Atricure
                    Inogen

                    Ownership Overview

                    18.32%<0.01%78.37%
                    Insiders
                    <0.01% Other Institutional Investors
                    78.37% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis